Current Edition

AbbVie

AbbVie’s Imbruvica patent win sets up solid growth path after Humira’s decline: analyst

Don’t sleep on AbbVie’s recent federal court victory which upheld its patents on big-selling cancer drug Imbruvica, warns one influential biopharma analyst. In the case, …

Continue Reading →